In the cancer setting, the primary readout is IFNg, secreted by CD8+ T cells and Th1 cells, but inclusion of IL-5 as a second cytokine comes with only minor additional costs in the Fluorospot assay and can provide insights on the presence of epitope specific Th2 cells. The gene discussed is CD8A; the disease is cancer.